Keros Therapeutics, Inc. (KROS)
17.57
+0.33
(+1.91%)
USD |
NASDAQ |
Feb 06, 16:00
17.54
-0.03
(-0.17%)
After-Hours: 20:00
Keros Therapeutics SG&A Expense (TTM) : 45.77M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 353.07M |
| MannKind Corp. | 195.42M |
| Sarepta Therapeutics, Inc. | 527.29M |
| Insmed, Inc. | 631.20M |
| Ionis Pharmaceuticals, Inc. | 351.68M |